Abstract
The effect of a novel Na+-H+ exchange inhibitor, SM-20550 [N-(aminoiminomethyl)-1,4-dimethyl-1H-indole-2-carboxamide methanesulfonate] (SM) on the ion transport of myocardial mitochondria was studied using ion fluorometry and superfusion techniques. Isolated mitochondria from the guinea-pig heart were pre-loaded with fluoroprobes of either BCECF AM for H+, SBFI AM for Na+ or fura-2 AM for Ca2+. Initially, the treated mitochondria were superfused with a normal medium (MOPS-buffer, pH 7.4, 24°C), subsequently fluorometric experiments on the Na+, H+, Ca2+ mobilization across the mitochondrial membrane were performed. The intramitochondrial pH (pHm) was increased by the superfusion of Na+ at physiological cytosolic concentrations of 10 mM, indicating the existence of a Na+-H+ exchange in mitochondrial membranes. The Na+ induced elevation of pHm was dose-dependently inhibited by SM 1 μM (ΔpHm; 45% as drug-free 100%), and 10 μM (ΔpHm; 70%(, as observed in our experiments with the myocardial sarcolemmal membrane. The selective Na+-H+ exchange inhibitor SM reduced such pHm elevations more markedly than that of EIPA [5-(N-ethyl-N-isopropyl) amiloride]. The Na+-H+ exchange inhibitors, SM and EIPA suppressed the intramitochondrial Ca2+ elevation ([Ca2+]m) brought on by external Ca2+ concentration changes: The pretreatment with SM 1 μM, 10 μM and EIPA 10 μM reduced the [Ca2+]m influx by 28.3, 56.5 and 63%, respectively. Additionally, the [Ca2+]m elevation induced by acidification of the perfusate was reduced by the prior infusion of SM and EIPA. Pretreatment of mitochondria with SM or EIPA which had beneficial effects on the left ventricular developed pressure (LVDP) in the ischemia-reperfusion injury of Langendorff hearts, reduced the intramitochondrial Na+ and pHm levels, indicating interplay of the inhibitory mechanism of Ca2+-uptake into mitochondria coupled with Na+-H+ exchange. These findings suggested that protective effects of Na+-H+ exchange inhibitors on reperfused myocardium are due in part to the Ca2+-paradox at the mitochondria level.
Similar content being viewed by others
References
Karmazyn M, Gan XT, Humphreys RA, Yoshida H, Kusumoto K: The myocardial Na+-H+ exchange structure, regulation, and its role in heart disease. Circ Res 85: 777–786, 1999
Ito Y, Imai S, Ui G, Nakano M, Imai K, Kamiyama H, Naganuma F, Matui K, Ohashi N. A: Na+-H+ exchange inhibitor (SM-20550) protects from microvascular deterioration and myocardial injury after reperfusion. Eur J Pharmacol 374: 355–366, 1999
Matsui K, Toda H, Noguchi T, Matsushita K, Sasabe M, Kitano M, Ohashi N: Cardioprotective effect of a new Na+/H+ exchange inhibitor, SM-20550, on ischemic reperfusion injury. Jpn J Pharmacol 73(suppl 1): 232P, 1997
Yamamoto S, Matui K, Kitaro M, Ohashi N: SM-20550, a new Na+/ H+ exchange inhibitor and its cardioprotective effect in ischemiareperfusion isolated rat hearts by preventing Ca2+-overload. J Cardiovasc Pharmacol 35: 855–862, 2000
Yamada K, Matsui K, Satoh K, Kitano M, Yamamoto S, Ohashi N: Reduction of myocardial infarct size by SM-20550, a novel Na+/ H+ exchange inhibitor, in rabbits. Eur J Pharmacol 404: 201–212, 2000
Hotta Y, Nakagawa J, Wakida Y, Ishikawa N, Ando H, Takeya K, Ohashi N, Matsui K: Protective effect of SM-20550, a selective Na+-H+ exchange inhibitor, on ischemia-reperfusion injured hearts. J Cardiovasc Pharmacol (in press)
Hotta Y, Fujita M, Nakagawa J, Ando H, Takeya K, Sakakibara J: The contribution of cytosolic ionic and energetic milieu change to ischemiaand reperfused-induced injury in guinea-pig heart: Fluorometry and nuclear magnetic resonance studies. J Cardiovasc Pharmacol 31: 146–156, 1998
Hotta Y, Otsuka-Murakami H, Fujita M, Nakagawa J, Yajima M, Ishikawa N, Kawai N, Masumizu T, Kohno M: Protective role of nitric oxide synthase in myocardial mitochondria against ischemiareperfusion injury in guinea pigs. Eur J Pharmacol 380: 37–48, 1999
Koike A, Abe T, Hotta Y, Takeya K, Kodama I, Toyama J: Protective effects of dimethyl amiloride, a potent Na+-H+ exchange inhibitor, against post-ischemic myocardial dysfunction: 31P-NMR measurements of pHi and cellular energy in isolated perfused rabbit hearts. J Thorac Cardiovasc Surg 112: 765–775, 1996
Karmazyn M: Ischemic and reperfusion injury in the heart. Cellular mechanisms and pharmacological interventions. Can J Physiol Phamacol 69: 719–730, 1991
Duan J, Karmazyn M: Relationship between oxidative phosphorylation and adenine nucleotide translocase activity of two populations of cardiac mitochondria and mechanical recovery of ischemic hearts following reperfusion. Can J Physiol Phamacol 67: 704–709, 1989
Hendrikx M, Mubagwa K, Verdonck F, Overloop K, Hecke PV, Vanstapel F, Lommel AV, Verbeken E, Lauweryns J, Flemeng W: New Na+-H+ exchange inhibitor HOE 694 improves postischemic function and high-energy phosphate resynthesis and reduces Ca2+ overload in isolated perfused rabbit heart. Circulation 89: 2787–2798, 1994
Kaneko M, Matsumoto Y, Hayashi H, Kobayashi A, Yamazaki N: Oxygen free radicals and calcium homeostasis in the heart. Mol Cell Biochem 139: 91–100, 1994
Brierley GP, Jurkowitz MS, Farooqui T, Jung DW: K+/H+ antiport in heart mitochondria. J Biol Chem 259: 14672–14678, 1984
James-Kracke MR: Quick and accurate method to convert BCECF fluorescence to pHi: Calibration in three different types of cell preparations. J Cell Physiol 151: 596–603, 1992
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275, 1951
Hotta Y, Nishiyama M, Ando H, Kato M, Takeya K: Different modes of the effects of dihydroouabain and isoproterenol on the fura-2 calcium transients and contractile response of the isolated guinea-pig heart. J Aichi Med Univ Assoc 17: 911–915, 1989
Hotta Y, Ando H, Fujita M, Nakagawa J, Takeya K, Sakakibara J: Different effects of isoproterenol and dihydroouabain on cardiac Ca2+ transients. Eur J Pharmacol 282: 121–130, 1995
Cox DA, Matlib MA: A role for the mitochondrial Na+-Ca2+ exchanger in regulation of oxidative phosphorylation in isolated heart mitochondria. J Biol Chem 268: 938–947, 1993
Jung DW, Baysal K, Brierley GP: The sodium-calcium antiport of heart mitochondria is not electroneutral. J Biol Chem 270: 672–678, 1995
Brierley GP, Davis MH, Cragoe EJ, Jung DW: Kinetic properties of the Na+/H+ antiport of heart mitochondria. Biochemistry 28: 4347–4354, 1989
Kapus A, Ligeti E, Fonyo A: Na+/H+ exchange in mitochondria as monitored by BCECF fluorescence. FEBS Lett 251: 49–52, 1989
Welihinda AA, Trumbly RJ, Garlid KD, Beavis AD: On the regulation of Na+/H+ and K+/H+ antiport in yeast mitochondria: Evidence for the absence of a Na+-selective Na+/H+ antiporter. Biochim Biophys Acta 1144: 367–373, 1993
Numata M, Petrecca K, Lake N, Orlowski J: Identification of a mitochondrial Na+/H+ exchanger. J Biol Chem 273: 6951–6959, 1998
Manon S, Guerin M: K+/H+ exchange in yeast mitochondria; sensitivity to inhibitors, solubilization and reconstitution of the activity in proteoliposomes. Biochem Biophs Acta 1108: 169–176, 1992
Beavis AD, Lu Y, Garlid KD: On the regulation of K+ uniport in intact mitochondria by adenine nucleotides and nucleotide analogs. J Biol Chem 268: 997–1004, 1993
Hotta Y, Takeya K: Cytosolic electrolytes change in ischemia and reperfusion of the heart under drug action, 6th International symposium on pharmacological control of calcium and potassium homeostasis, biological, therapeutical and clinical aspects. Florence (Italy), 54, 1994
Takeya K, Hotta Y: The role of mitochondria for the contractility regulation of calcium ions in ischemic myocardium. Cytosolic electrolytes change in ischemia and reperfusion of the heart under drug action, 6th International symposium on pharmacological control of calcium and potassium homeostasis, biological, therapeutical and clinical aspects. Florence (Italy), 39, 1994
Nass R, Rao R: Novel localization of a Na+-H+ exchanger in a late endosomal compartment of yeast. J Biol Chem 273: 21054–21060, 1998
Myers ML, Farhangkhoee P, Karmazyn M: Hydrogen peroxide induced impairment of post-ischemic ventricular function is prevented by the sodium-hydrogen exchange inhibitor HOE 642 (cariporide). Cardiovasc Res 40: 290–296, 1998
Dhalla NS, Elmoselhi AB, Hata T, Makino N: Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 47: 446–456, 2000
Czarnowska E, Karwatowska-Prokopczuk E, Kurzydlowski K: Ultrastructural study of calcium shift in ischemia/reperfused rat heart under treatment with dimethylthiourea, diltiazem and amiloride. Basic Res Cardiol 93: 269–275, 1998
Crompton M, Heid I: The cycling of calcium, sodium, and protons across the inner membrane of cardiac mitochondria. Eur J Biochem 91: 599–608, 1978
Ruβ U, Balser C, Scholz W, Albus U, Lang HJ, Weichert A, Schölkens BA, Gögeleine H: Effects of the Na+/H+-exchange inhibitor Hoe 642 on intracellular pH, calcium and sodium in isolated rat ventricular myocytes. Pflügers Arch-Eur J Physiol 433: 26–34, 1996
Miyata H, Lakatta EG, Stern MD, Silverman HS: Relation of mitochondrial and cytosolic free calcium to cardiac myocyte recovery after exposure to anoxia. Circ Res 71: 605–613, 1992
Allen SP, Darley-Usmar VM, McCormack JG, Stone D: Changes in mitochondrial matrix free calcium in perfused rat hearts subjected to hypoxia-reperfusion. J Mol Cell Cardiol 25: 949–958, 1993
Demaison L, Moreau D, Martine L, Chaudron I, Grynberg A: Myocardial ischemia and in vitro mitochondrial metabolic efficiency. Mol Cell Biochem 158: 161–169, 1996
Asimakis GK, Sordahl LA: Intramitochondrial adenine nucleotides and energy-linked functions of heart mitochondria. Am J Physiol 241: H672–H678, 1981
Gunter TE, Gunter KK, Sheu S-S, Gavin, CE: Mitochondria calcium transport: Physiological and pathological relevance. Am J Physiol 267: C313–C319, 1994
Reers M, Kelly RA, Smith TW: Calcium and proton activities in rat cardiac mitochondria: Effect of matrix environment on behaviour of fluorescent probes. Biochem J 257: 131–142, 1989
Hearse DJ: Reperfusion of the ischemic myocardium. J Mol Cell Cardiol 9: 605–616, 1977
Kroemer G, Dallaporta B, Resche-Rigon M: The mitochondrial death/ life regulation in apoptosis and necrosis. Annu Rev Physiol 60: 619–642, 1998
Chakrabarti S, Hoque ANE, Karmazyn M: A rapid ischemia-induced apoptosis in isolated rat hearts and its attenuation by the sodium-hydrogen exchange inhibitor HOE 642 (Cariporide). J Mol Cell Cardiol 29: 3169–3174, 1997
Sailer BL, Barrasso AM, Valdez JG, Cobo JM, D'Anna JA, Crissman HA: Reduction in the radiation-induced late S phase and G2 blocks in HL-60 cell populations by amiloride, an efficient inhibitor of the Na+/ H+ transporter. Cancer Res 58: 413–420, 1998
Humphreys RA, Haist JV, Chakrabarti S, Feng Q, Arnold JM, Karmazyn M: Orally administered NHE1 inhibitor cariporide reduces acute responses to coronary occlusion and reperfusion. Am J Physiol 276: H749–H757, 1999
Liu W, Kato M, Akhand AA, Hayakawa A, Suzuki H, Miyata T, Kurokawa, Hotta Y, Ishikawa N, Nakasima I: 4-hydrooxynonenatal independent redox-related activation of caspase-3. J Cell Sci 113: 635–641, 2000
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hotta, Y., Ishikawa, N., Ohashi, N. et al. Effects of SM-20550, a selective Na+-H+ exchange inhibitor, on the ion transport of myocardial mitochondria. Mol Cell Biochem 219, 83–90 (2001). https://doi.org/10.1023/A:1011019010140
Issue Date:
DOI: https://doi.org/10.1023/A:1011019010140